Leonid Timashev
Stock Analyst at RBC Capital
(4.74)
# 684
Out of 5,073 analysts
536
Total ratings
48.2%
Success rate
15%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Rated: Buy | $48 | $35.47 | +35.33% | 13 | Oct 19, 2026 | |
| BHVN Biohaven | Reiterated: Hold | $19 | $11.75 | +61.70% | 33 | Oct 16, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 | $2.30 | +508.70% | 11 | Oct 16, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $459 | $386.46 | +18.77% | 19 | Oct 16, 2026 | |
| XNCR Xencor | Reiterated: Buy | $20 | $25.16 | -20.51% | 9 | Oct 16, 2026 | |
| VSTM Verastem | Rated: Buy | $14 → $19 | $9.21 | +106.30% | 18 | Oct 15, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $295 | $156.31 | +88.73% | 43 | Oct 14, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $113 | $62.86 | +79.76% | 28 | Oct 14, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $259 → $260 | $194.28 | +33.83% | 17 | Oct 14, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $20 | $4.85 | +312.37% | 15 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 → $51 | $64.58 | -21.03% | 18 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.50 | +33.33% | 19 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $43.48 | +28.79% | 24 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.79 | +79.72% | 17 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $94.04 | +107.36% | 27 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $299 → $296 | $211.97 | +39.64% | 16 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $56 | $18.63 | +200.59% | 48 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.76 | +240.91% | 20 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $42 | $21.49 | +95.44% | 28 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $39.65 | +48.80% | 43 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $287 | $257.78 | +11.34% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $79 | $62.24 | +26.93% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $449 → $462 | $256.47 | +80.14% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $21 | $11.84 | +77.36% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.73 | +86.39% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.57 | +40.06% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.5043 | +494.88% | 7 | May 14, 2026 |
IDEAYA Biosciences
Oct 19, 2026
Rated: Buy
Price Target: $48
Current: $35.47
Upside: +35.33%
Biohaven
Oct 16, 2026
Reiterated: Hold
Price Target: $19
Current: $11.75
Upside: +61.70%
Perspective Therapeutics
Oct 16, 2026
Reiterated: Buy
Price Target: $14
Current: $2.30
Upside: +508.70%
BeOne Medicines AG
Oct 16, 2026
Reiterated: Buy
Price Target: $459
Current: $386.46
Upside: +18.77%
Xencor
Oct 16, 2026
Reiterated: Buy
Price Target: $20
Current: $25.16
Upside: -20.51%
Verastem
Oct 15, 2026
Rated: Buy
Price Target: $14 → $19
Current: $9.21
Upside: +106.30%
Axsome Therapeutics
Oct 14, 2026
Reiterated: Buy
Price Target: $295
Current: $156.31
Upside: +88.73%
Cytokinetics
Oct 14, 2026
Reiterated: Buy
Price Target: $113
Current: $62.86
Upside: +79.76%
Revolution Medicines
Oct 14, 2026
Reiterated: Buy
Price Target: $259 → $260
Current: $194.28
Upside: +33.83%
Nuvation Bio
Oct 12, 2026
Reiterated: Buy
Price Target: $20
Current: $4.85
Upside: +312.37%
Oct 9, 2026
Reiterated: Hold
Price Target: $46 → $51
Current: $64.58
Upside: -21.03%
Oct 8, 2026
Reiterated: Hold
Price Target: $2
Current: $1.50
Upside: +33.33%
Oct 8, 2026
Reiterated: Buy
Price Target: $56
Current: $43.48
Upside: +28.79%
Oct 8, 2026
Reiterated: Buy
Price Target: $14
Current: $7.79
Upside: +79.72%
Oct 8, 2026
Reiterated: Buy
Price Target: $195
Current: $94.04
Upside: +107.36%
Oct 8, 2026
Reiterated: Buy
Price Target: $299 → $296
Current: $211.97
Upside: +39.64%
Oct 8, 2026
Reiterated: Buy
Price Target: $58 → $56
Current: $18.63
Upside: +200.59%
Oct 8, 2026
Reiterated: Buy
Price Target: $6
Current: $1.76
Upside: +240.91%
Oct 5, 2026
Reiterated: Buy
Price Target: $50 → $42
Current: $21.49
Upside: +95.44%
Sep 22, 2026
Reiterated: Buy
Price Target: $59
Current: $39.65
Upside: +48.80%
Sep 9, 2026
Reiterated: Buy
Price Target: $287
Current: $257.78
Upside: +11.34%
Aug 6, 2026
Reiterated: Buy
Price Target: $81 → $79
Current: $62.24
Upside: +26.93%
Aug 6, 2026
Rated: Buy
Price Target: $449 → $462
Current: $256.47
Upside: +80.14%
Aug 5, 2026
Rated: Buy
Price Target: $22 → $21
Current: $11.84
Upside: +77.36%
Aug 3, 2026
Reiterated: Buy
Price Target: $20
Current: $10.73
Upside: +86.39%
Jul 30, 2026
Reiterated: Hold
Price Target: $5
Current: $3.57
Upside: +40.06%
May 14, 2026
Reiterated: Hold
Price Target: $4 → $3
Current: $0.5043
Upside: +494.88%